Cargando…

Screening of pregnant Saudi women for hepatitis B surface antigen

BACKGROUND: The high prevalence of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) in pregnant women is considered the most important factor contributing to the higher carrier rate of HBsAg in some populations, including Saudi Arabia. Universal hepatitis B vaccination in infanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mazrou, Yagob Y., Al-Jeffri, Mohamed, Khalil, Mohamed K.M., Al-Ghamdi, Yasser S., Mishkhas, Ameen, Bakhsh, Mohamed, Eisa, Mostafa, Nageeb, Mohamed, Tumsah, Salah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148127/
https://www.ncbi.nlm.nih.gov/pubmed/15387491
http://dx.doi.org/10.5144/0256-4947.2004.265
_version_ 1783356704591708160
author Al-Mazrou, Yagob Y.
Al-Jeffri, Mohamed
Khalil, Mohamed K.M.
Al-Ghamdi, Yasser S.
Mishkhas, Ameen
Bakhsh, Mohamed
Eisa, Mostafa
Nageeb, Mohamed
Tumsah, Salah
author_facet Al-Mazrou, Yagob Y.
Al-Jeffri, Mohamed
Khalil, Mohamed K.M.
Al-Ghamdi, Yasser S.
Mishkhas, Ameen
Bakhsh, Mohamed
Eisa, Mostafa
Nageeb, Mohamed
Tumsah, Salah
author_sort Al-Mazrou, Yagob Y.
collection PubMed
description BACKGROUND: The high prevalence of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) in pregnant women is considered the most important factor contributing to the higher carrier rate of HBsAg in some populations, including Saudi Arabia. Universal hepatitis B vaccination in infancy was implemented in Saudi Arabia in 1990 to avoid early acquisition of infection. At the same time, another program was launched to vaccinate all school children at school entry as a second target group. The aim of this study was to evaluate the HBsAg prevalence rate in Saudi pregnant women 12 years after launching the program and to assess regional variation, if any. METHODS: In a cross-sectional study, 2664 pregnant Saudi women were recruited from the five main regions in Saudi Arabia. Blood samples were tested for HBsAg. Positive samples were tested also for HBeAg. RESULTS: Of 2664 pregnant Saudi women, 65 were positive for HBsAg (2.46%, 95% Cl=2.11 %– 2.69%). Four were positive for HBeAg (0.15%). The HBsAg prevalence rate was higher in Gizan (4.2%) and lower in Tabuk (1.4%) (P=0.035). Only one case was positive for HBsAg in women under the age of 20 years (1/186), a 0.5% positivity rate in this age group compared with 2.6% in the older age group (P=0.049 for the one-sided test). A history of surgical procedures was associated with a higher (3%), but not significantly higher rate of HBsAg positivity. No significant association was found between HBsAg positivity and a history of dental procedures or blood transfusion. CONCLUSION: Although the HBsAg prevalence rate among Saudi pregnant women was lower than previously published data, the full impact of the hepatitis B vaccination program in infancy and childhood will take more years to decrease the prevalence rate in pregnant women. The MOH should continue to give the first dose of hepatitis B vaccine at birth to prevent early acquisition, but in the meantime a regional policy can be adopted to deal with the high prevalence rate of HBsAg among pregnant Saudi women.
format Online
Article
Text
id pubmed-6148127
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher King Faisal Specialist Hospital and Research Centre
record_format MEDLINE/PubMed
spelling pubmed-61481272018-09-21 Screening of pregnant Saudi women for hepatitis B surface antigen Al-Mazrou, Yagob Y. Al-Jeffri, Mohamed Khalil, Mohamed K.M. Al-Ghamdi, Yasser S. Mishkhas, Ameen Bakhsh, Mohamed Eisa, Mostafa Nageeb, Mohamed Tumsah, Salah Ann Saudi Med Original Article BACKGROUND: The high prevalence of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) in pregnant women is considered the most important factor contributing to the higher carrier rate of HBsAg in some populations, including Saudi Arabia. Universal hepatitis B vaccination in infancy was implemented in Saudi Arabia in 1990 to avoid early acquisition of infection. At the same time, another program was launched to vaccinate all school children at school entry as a second target group. The aim of this study was to evaluate the HBsAg prevalence rate in Saudi pregnant women 12 years after launching the program and to assess regional variation, if any. METHODS: In a cross-sectional study, 2664 pregnant Saudi women were recruited from the five main regions in Saudi Arabia. Blood samples were tested for HBsAg. Positive samples were tested also for HBeAg. RESULTS: Of 2664 pregnant Saudi women, 65 were positive for HBsAg (2.46%, 95% Cl=2.11 %– 2.69%). Four were positive for HBeAg (0.15%). The HBsAg prevalence rate was higher in Gizan (4.2%) and lower in Tabuk (1.4%) (P=0.035). Only one case was positive for HBsAg in women under the age of 20 years (1/186), a 0.5% positivity rate in this age group compared with 2.6% in the older age group (P=0.049 for the one-sided test). A history of surgical procedures was associated with a higher (3%), but not significantly higher rate of HBsAg positivity. No significant association was found between HBsAg positivity and a history of dental procedures or blood transfusion. CONCLUSION: Although the HBsAg prevalence rate among Saudi pregnant women was lower than previously published data, the full impact of the hepatitis B vaccination program in infancy and childhood will take more years to decrease the prevalence rate in pregnant women. The MOH should continue to give the first dose of hepatitis B vaccine at birth to prevent early acquisition, but in the meantime a regional policy can be adopted to deal with the high prevalence rate of HBsAg among pregnant Saudi women. King Faisal Specialist Hospital and Research Centre 2004 /pmc/articles/PMC6148127/ /pubmed/15387491 http://dx.doi.org/10.5144/0256-4947.2004.265 Text en Copyright © 2004, Annals of Saudi Medicine This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Al-Mazrou, Yagob Y.
Al-Jeffri, Mohamed
Khalil, Mohamed K.M.
Al-Ghamdi, Yasser S.
Mishkhas, Ameen
Bakhsh, Mohamed
Eisa, Mostafa
Nageeb, Mohamed
Tumsah, Salah
Screening of pregnant Saudi women for hepatitis B surface antigen
title Screening of pregnant Saudi women for hepatitis B surface antigen
title_full Screening of pregnant Saudi women for hepatitis B surface antigen
title_fullStr Screening of pregnant Saudi women for hepatitis B surface antigen
title_full_unstemmed Screening of pregnant Saudi women for hepatitis B surface antigen
title_short Screening of pregnant Saudi women for hepatitis B surface antigen
title_sort screening of pregnant saudi women for hepatitis b surface antigen
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148127/
https://www.ncbi.nlm.nih.gov/pubmed/15387491
http://dx.doi.org/10.5144/0256-4947.2004.265
work_keys_str_mv AT almazrouyagoby screeningofpregnantsaudiwomenforhepatitisbsurfaceantigen
AT aljeffrimohamed screeningofpregnantsaudiwomenforhepatitisbsurfaceantigen
AT khalilmohamedkm screeningofpregnantsaudiwomenforhepatitisbsurfaceantigen
AT alghamdiyassers screeningofpregnantsaudiwomenforhepatitisbsurfaceantigen
AT mishkhasameen screeningofpregnantsaudiwomenforhepatitisbsurfaceantigen
AT bakhshmohamed screeningofpregnantsaudiwomenforhepatitisbsurfaceantigen
AT eisamostafa screeningofpregnantsaudiwomenforhepatitisbsurfaceantigen
AT nageebmohamed screeningofpregnantsaudiwomenforhepatitisbsurfaceantigen
AT tumsahsalah screeningofpregnantsaudiwomenforhepatitisbsurfaceantigen